FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine. As an agent possessing antiarrhythmic, antifibrillatory and anti-ischemic action, 1-(2-diethylaminoethyl)-2-phenylimidazo[1,2-a]benzimidazole dihydrochloride of formula is used. A composition possessing antiarrhythmic, antifibrillatory and anti-ischemic action contains a compound of formula I taken in an effective amount as an active ingredient.
EFFECT: declared group of inventions possess high antiarrhythmic, antifibrillatory and anti-ischemic action.
2 cl, 3 dwg, 12 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
ANTIARRYTHMIC AGENT | 1983 |
|
RU2068261C1 |
METHOD OF PREVENTION OF HEART RHYTHM DISORDER | 2007 |
|
RU2348408C1 |
METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
PHARMACEUTICAL COMPOSITION PREVENTING DEVELOPMENT OF PREEXCITATION SYNDROME | 2011 |
|
RU2453313C1 |
AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
METHOD FOR DETERMINING ELECTROPHYSIOLOGICAL MECHANISMS OF EXTRASYSTOLIA DEVELOPMENT | 1998 |
|
RU2214161C2 |
N-1-[(4-FLUOROPHENYL)-2-(1-ETHYL-4-PIPERIDYL)-ETHYL]-4-NITROBENZAMIDE HYDROCHLORIDE EXHIBITING ANTIARHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 2009 |
|
RU2415128C2 |
AGENT HAVING CARDIOTONIC ACTIVITY | 2012 |
|
RU2521213C1 |
Authors
Dates
2013-03-10—Published
2011-07-12—Filed